These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 32468331)

  • 1. Prescription of memantine during non-stereotactic, brain-directed radiation among patients with brain metastases: a population-based study.
    Lamba N; Mehanna E; Kearney RB; Catalano PJ; Brown PD; Haas-Kogan DA; Aizer AA
    J Neurooncol; 2020 Jul; 148(3):509-517. PubMed ID: 32468331
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Memantine for the prevention of cognitive dysfunction in patients receiving whole-brain radiotherapy: a randomized, double-blind, placebo-controlled trial.
    Brown PD; Pugh S; Laack NN; Wefel JS; Khuntia D; Meyers C; Choucair A; Fox S; Suh JH; Roberge D; Kavadi V; Bentzen SM; Mehta MP; Watkins-Bruner D;
    Neuro Oncol; 2013 Oct; 15(10):1429-37. PubMed ID: 23956241
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The impact of RTOG 0614 and RTOG 0933 trials in routine clinical practice: The US Survey of Utilization of Memantine and IMRT planning for hippocampus sparing in patients receiving whole brain radiotherapy for brain metastases.
    Slade AN; Stanic S
    Contemp Clin Trials; 2016 Mar; 47():74-7. PubMed ID: 26718093
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hippocampal Avoidance During Whole-Brain Radiotherapy Plus Memantine for Patients With Brain Metastases: Phase III Trial NRG Oncology CC001.
    Brown PD; Gondi V; Pugh S; Tome WA; Wefel JS; Armstrong TS; Bovi JA; Robinson C; Konski A; Khuntia D; Grosshans D; Benzinger TLS; Bruner D; Gilbert MR; Roberge D; Kundapur V; Devisetty K; Shah S; Usuki K; Anderson BM; Stea B; Yoon H; Li J; Laack NN; Kruser TJ; Chmura SJ; Shi W; Deshmukh S; Mehta MP; Kachnic LA;
    J Clin Oncol; 2020 Apr; 38(10):1019-1029. PubMed ID: 32058845
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Palliative whole brain radiation therapy: an international state of practice.
    Keit E; Lee SF; Woodward M; Rembielak A; Shiue K; Desideri I; Oldenburger E; Bienz M; Rades D; Theodorou M; Agyeman MB; Yarney J; Bryant JM; Yu HM; Simone CB; Hoskin P; Johnstone PAS
    Ann Palliat Med; 2023 Nov; 12(6):1155-1164. PubMed ID: 37731303
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A pilot study using dynamic contrast enhanced-MRI as a response biomarker of the radioprotective effect of memantine in patients receiving whole brain radiotherapy.
    Wong P; Leppert IR; Roberge D; Boudam K; Brown PD; Muanza T; Pike GB; Chankowsky J; Mihalcioiu C
    Oncotarget; 2016 Aug; 7(32):50986-50996. PubMed ID: 27248467
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Local control after brain-directed radiation in patients with cystic versus solid brain metastases.
    Brigell RH; Cagney DN; Martin AM; Besse LA; Catalano PJ; Lee EQ; Wen PY; Brown PD; Phillips JG; Pashtan IM; Tanguturi SK; Haas-Kogan DA; Alexander BM; Aizer AA
    J Neurooncol; 2019 Apr; 142(2):355-363. PubMed ID: 30715665
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost-effectiveness of stereotactic radiosurgery versus whole-brain radiation therapy for up to 10 brain metastases.
    Lester-Coll NH; Dosoretz AP; Magnuson WJ; Laurans MS; Chiang VL; Yu JB
    J Neurosurg; 2016 Dec; 125(Suppl 1):18-25. PubMed ID: 27903191
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of Apolipoprotein E Genotype on Neurocognitive Function in Patients With Brain Metastases: An Analysis of NRG Oncology's RTOG 0614.
    Wefel JS; Deshmukh S; Brown PD; Grosshans DR; Sulman EP; Cerhan JH; Mehta MP; Khuntia D; Shi W; Mishra MV; Suh JH; Laack NN; Chen Y; Curtis AA; Laba JM; Elsayed A; Thakrar A; Pugh SL; Bruner DW
    Int J Radiat Oncol Biol Phys; 2024 Jul; 119(3):846-857. PubMed ID: 38101486
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sustained Preservation of Cognition and Prevention of Patient-Reported Symptoms With Hippocampal Avoidance During Whole-Brain Radiation Therapy for Brain Metastases: Final Results of NRG Oncology CC001.
    Gondi V; Deshmukh S; Brown PD; Wefel JS; Armstrong TS; Tome WA; Gilbert MR; Konski A; Robinson CG; Bovi JA; Benzinger TLS; Roberge D; Kundapur V; Kaufman I; Shah S; Usuki KY; Baschnagel AM; Mehta MP; Kachnic LA
    Int J Radiat Oncol Biol Phys; 2023 Nov; 117(3):571-580. PubMed ID: 37150264
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Strategies for preservation of memory function in patients with brain metastases.
    Dye NB; Gondi V; Mehta MP
    Chin Clin Oncol; 2015 Jun; 4(2):24. PubMed ID: 26112810
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hippocampal avoidance whole-brain radiotherapy without memantine in preserving neurocognitive function for brain metastases: a phase II blinded randomized trial.
    Yang WC; Chen YF; Yang CC; Wu PF; Chan HM; Chen JL; Chen GY; Cheng JC; Kuo SH; Hsu FM
    Neuro Oncol; 2021 Mar; 23(3):478-486. PubMed ID: 32789503
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neurocognition in patients with brain metastases treated with radiosurgery or radiosurgery plus whole-brain irradiation: a randomised controlled trial.
    Chang EL; Wefel JS; Hess KR; Allen PK; Lang FF; Kornguth DG; Arbuckle RB; Swint JM; Shiu AS; Maor MH; Meyers CA
    Lancet Oncol; 2009 Nov; 10(11):1037-44. PubMed ID: 19801201
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypofractionated stereotactic radiotherapy with or without whole-brain radiotherapy for patients with newly diagnosed brain metastases from non-small cell lung cancer.
    Ma LH; Li G; Zhang HW; Wang ZY; Dang J; Zhang S; Yao L; Zhang XM
    J Neurosurg; 2012 Dec; 117 Suppl():49-56. PubMed ID: 23205789
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stereotactic Radiosurgery Versus Whole Brain Radiation Therapy: A Propensity Score Analysis and Predictors of Care for Patients With Brain Metastases From Breast Cancer.
    Mainwaring W; Bowers J; Pham N; Pezzi T; Shukla M; Bonnen M; Ludwig M
    Clin Breast Cancer; 2019 Apr; 19(2):e343-e351. PubMed ID: 30527350
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prophylactic Cranial Irradiation for Limited-Stage Small-Cell Lung Cancer: Survey of US Radiation Oncologists on Current Practice Patterns.
    Farrell MJ; Yahya JB; Degnin C; Chen Y; Holland JM; Henderson MA; Jaboin JJ; Harkenrider MM; Thomas CR; Mitin T
    Clin Lung Cancer; 2018 Jul; 19(4):371-376. PubMed ID: 29559208
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of whole-brain radiation therapy after stereotactic radiation surgery for brain metastases.
    Hasan S; Shah AH; Bregy A; Albert T; Markoe A; Stoyanova R; Thambuswamy M; Komotar RJ
    Pract Radiat Oncol; 2014; 4(5):306-315. PubMed ID: 25194099
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preservation of cognitive function following whole brain radiotherapy in patients with brain metastases: Complications, treatments, and the emerging role of memantine.
    Lynch M
    J Oncol Pharm Pract; 2019 Apr; 25(3):657-662. PubMed ID: 30200844
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Decision analysis of stereotactic radiation surgery versus stereotactic radiation surgery and whole-brain radiation therapy for 1 to 3 brain metastases.
    Lester-Coll NH; Dosoretz AP; Yu JB
    Int J Radiat Oncol Biol Phys; 2014 Jul; 89(3):563-8. PubMed ID: 24751412
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of Stereotactic Radiosurgery in Elderly and Very Elderly Patients With Brain Metastases to Limit Toxicity Associated With Whole Brain Radiation Therapy.
    Chen L; Shen C; Redmond KJ; Page BR; Kummerlowe M; Mcnutt T; Bettegowda C; Rigamonti D; Lim M; Kleinberg L
    Int J Radiat Oncol Biol Phys; 2017 Jul; 98(4):939-947. PubMed ID: 28602418
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.